Document is current
Any future updates will be listed below
-
Authors
Brockmann, Kathrin
Quadalti, Corinne
Lerche, Stefanie
Rossi, Marcello
Wurster, Isabel
Baiardi, Simone
Roeben, Benjamin
Mammana, Angela
Zimmermann, Milan
Hauser, Ann-Kathrin
Deuschle, Christian
Schulte, Claudia
Waniek, Katharina
Lachmann, Ingolf
Sjödin, Simon
Brinkmalm, Ann
Blennow, Kaj
Zetterberg, Henrik
Gasser, Thomas
Parchi, Piero https://orcid.org/0000-0002-9444-9524
-
Funding
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente)
Fondazione Cassa di Risparmio di Bologna
DZNE (PD research)
BMBF (PD Dementia)
- License Information
-
More Information
Article History
Received: 14 September 2021
Accepted: 13 October 2021
First Online: 30 October 2021
Declarations
:
: The study was approved by the Ethics Committee of the University of Tuebingen (26/2007BO1, 404/2010BO1, 199/2011BO1, 702/2013BO1). All participants gave written informed consent.
: Not applicable.
: KW is employed by Roboscreen GmbH and receive income from that Company, which manufactures the ELISA kit for measurements of total human α-Syn used in the present study. IL is employed by Roboscreen GmbH and receive income from that Company, which manufactures the ELISA kit for measurements of total human α-Syn used in the present study. KB is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), of which biomarkers were measured for the present study. HZ is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), of which biomarkers were measured for the present study. KB, CQ, SL, MR, IW, SB, BR, MZ, AM, AKH, CD, CS, AB, and SS, TG, and PP have nothing to report.
